InvestorsHub Logo
Followers 121
Posts 12706
Boards Moderated 2
Alias Born 12/21/2017

Re: Ecomike post# 1014

Tuesday, 12/31/2019 3:45:17 PM

Tuesday, December 31, 2019 3:45:17 PM

Post# of 2868
$MILV ***Brain Trauma Repair***

So, this is what MILV will be able to do now that it has Michael W. Fountain's patent attached to it.

Most people are unaware that Vitamin E is essential for the bodies general over health, along with other Vitamin agents like A and C. The reason is because Vitamin E donates hydrogen for cell energy and repair.

Chief Scientist, Michael W. Fountain PhD, has licensed his patent to directly tackle this specific deficiency in medical application and medications. Studies have been done at Oregon State University back in 1987 that showed that Vitamin E efficacy in cell culture, simply wasn't being seen in rodent populations testing due to the "inactivity" of the Vitamin E and Vitamin E succinate compounds they were using.

What Michael W. Fountain and research team were able to develop was a "Vitamin E Phosphate" compound that wasn't inert, nor harmful to the liver upon breakdown.

Thus it could repair and now protect the liver when drugs like tetrahydroaminoacridine (THA) (A compound used effectively used to treat ALZHEIMERS, but toxic to the liver).

He has developed a liposome with

1. Long Shelf life (24 months),
2. Durability and Efficacy
3. Mass Production
4. One-step production
5. A protective compound for brain damage
6. Small liposome that can pass through BBB -- blood brain barrier


Read More about the patent application here:

https://ccabiotech.blogspot.com/p/patent.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.